Active BE 0764.522.425Public limited company

Cellaïon

Rue Granbonpré 11 ·1435 Mont-Saint-Guibert, Belgium· 5 yrs active

Sector: Activiteiten op het gebied van voeding (86995)

Conclusion Checked

The KBO register records legal situation 012 for Cellaïon (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. The 2024 annual accounts show negative equity (€-13.85M) and a net result of €-7.71M.

Based on the State Gazette, CBE and 4 annual accounts.

Key figures

Equity	€-13.85M
Net result	€-7.71M
Staff (FTE)	15.5
Better than sector	5%

Financial profile 5 of 5 axes measured · computed by Checked

41 / 100

Fragile profile, watch health in particular.

All 5 axes are computed from data Checked has read.

Health 0

Profitability 100

Solvency 41

Growth 32

Stability 34

Bankruptcy probability (12 mo) Checked model v1 · free

Dissolution or liquidation

The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.

Risk Assessment rule-based

0 / 100

High riskRegister: dissolution or liquidation

This score counts publications in the Belgian State Gazette only. The KBO register additionally records legal situation 012 for this company; it does not feed the figure above.

Trust signals 1 signals

Register: dissolution or liquidation

The KBO register records legal situation 012 for this company. This is today's state according to the register itself; the register carries no start date.

Administrative Flags0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Health barometer FY 2024 · computed

0 / 100 Critical

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024 and the legal situation the KBO register itself records. Indicative, not credit advice.

Financial overview4 NBB filings

Annual accounts filed on 18-07-2025 with the NBB · fiscal year 2024 · volledig

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (full schema)

Metric	This company	Sector median	Position in the sector
Solvency	-592.9%	51.9%	better than 5% of 260 sector peers
Net result	€-7.71M	€50k	better than 5% of 259 sector peers
Equity	€-13.85M	€126k	better than 5% of 260 sector peers
Gross operating margin	€-4.03M	€147k	better than 5% of 255 sector peers
Staff costs	€3.41M	€161k	higher than 95% of 118 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€-7.58M

+41.2% 21-24

Net profit

€-7.71M

+41.8% 21-24

Cash flow

€-7.60M

+41.4% 21-24

Total assets

€2.34M

-68.8% 21-24

Equity

€-13.85M

-125.5% 21-24

Working capital

€-376k

- 21-24

Employees (FTE)

16

-38.5% 21-24

Staff costs

€3.41M

+12.5% 21-24

Show 11 other metrics

Income taxes

€2k

-54.6% 21-24

Debt

€15.10M

+30.7% 21-24

Debt ≤ 1y

€2.50M

-18.5% 21-24

Debt > 1y

€12.61M

+48.4% 21-24

Current ratio

0.85

-59.4% 21-24

Quick ratio

0.85

-55.6% 21-24

Solvency

-592.9%

-622.8% 21-24

Debt / equity

-1.09

+42.0% 21-24

ROE

55.7%

-74.2% 21-24

ROA

-330.1%

-86.7% 21-24

Interest coverage

-105.13

-35.3% 21-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	volledig
Revenue	-
EBITDA	€-7.58M
Net profit	€-7.71M
Cash flow	€-7.60M
Staff costs	€3.41M
Income taxes	€2k
Dividends	-
Total assets	€2.34M
Equity	€-13.85M
Debt	€15.10M
of which ≤ 1y	€2.50M
of which > 1y	€12.61M
Working capital	€-376k
Employees (FTE)	15.5

Ratios (computed)

	2024
Current ratio	0.85
Quick ratio	0.85
Working capital ratio	-16.1%
Solvency	-592.9%
Debt / equity	-1.09
Long-term debt ratio	-0.91
Interest coverage	-105.13
Gross margin	-
Net margin	-
ROA	-330.1%
ROE	55.7%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	174d
Inventory turnover	-
Days inventory (DSI)	0d

Balance-sheet composition 2024

Assets

Fixed assets €214k · 9.2% Current assets €2.12M · 90.8%

Full annual accounts (27 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€2.34M
Fixed assets	21/28	€214k
Formation expenses	20	€0
Intangible fixed assets	21	€0
Tangible fixed assets	22/27	€0
Financial fixed assets	28	€214k
Current assets	29/58	€2.12M
Stocks & contracts in progress	3	€0
Amounts receivable within one year	40/41	€869k
Cash & bank	54/58	€1.25M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€2.34M
Equity	10/15	€-13.85M
Contributions / capital	10/11	€7.09M
Accumulated profits (losses)	14	€-20.94M
Provisions & deferred taxes	16	€1.08M
Amounts payable	17/49	€15.10M
Amounts payable after one year	17	€12.61M
Amounts payable within one year	42/48	€2.50M
Trade debts payable within one year	44	€2.49M
Income statement
Gross operating margin	9900	€-4.03M
Operating result	9901	€-7.69M
Financial income	75	€53k
Financial charges	65	€72k
Result before taxes	9903	€-7.71M
Income taxes	67/77	€2k
Net result for the period	9904	€-7.71M
Result to be appropriated	9905	€-7.71M

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	Activiteiten op het gebied van voeding(86995)
Legal form	Public limited company(014)
Incorporation	02-03-2021
Status	Active
Postal code	1435

Establishment units 1 location

-

Rue Granbonpré 11, 1435 Mont-Saint-GuibertSpeur- en ontwikkelingswerk op biotechnologisch gebied

since 20212.317.528.750

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25020B0074/00B002	Wallonia	6.2 ha	1 · 17 m²	7.8 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 9 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

18-07-2025

NBB filing Annual accounts filed

fiscal year 2024 · volledig

2024

15-07-2024

State Gazette act End of life

Kim LAGAE

27-06-2024

NBB filing Annual accounts filed

fiscal year 2023 · volledig

2023

23-06-2023

State Gazette act Capital & shares

Kim Lagae

09-06-2023

NBB filing Annual accounts filed

fiscal year 2022 · volledig

02-02-2023

State Gazette act Capital & shares

Kim LAGAE

2022

24-06-2022

NBB filing Annual accounts filed

fiscal year 2021 · volledig

09-02-2022

State Gazette act Capital & shares

Kim Lagae

26-01-2022

State Gazette act Capital & shares

Kim Lagae

Belgian State Gazette reading coverage 0 of 11 acts read

We know of 11 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 5 acts

Capital history · 4

23-06-2023

Capital change

02-02-2023

Capital change

09-02-2022

Capital change

26-01-2022

Capital change

All acts · 5 updated 2 years ago

2024

15-07-2024 Dissolution with immediate closure of the liquidation End of life·Kim LAGAE

Ontbinding: 2024-06-03

Notary: Kim LAGAE · Bruxelles

Original publication ↗

Technical details

{
  "notary": {
    "name": "Kim LAGAE",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "auditor": null,
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-07-15",
    "filing_date": null,
    "act_kind_objet": "DISSOLUTION DE LA SOCIETE - NOMINATION D\u0027UN LIQUIDATEUR-"
  },
  "decision": {
    "body": "assembl\u00E9e_g\u00E9n\u00E9rale_extraordinaire",
    "act_date": "2024-06-03",
    "unanimous": null
  },
  "end_event": {
    "reason": "Dissolution par assembl\u00E9e g\u00E9n\u00E9rale",
    "art_wvv": [
      "2:88"
    ],
    "sub_type": "voluntary_dissolution_with_close",
    "closure_effective_date": null,
    "dissolution_effective_date": "2024-06-03",
    "closure_effective_date_is_approximate": false,
    "dissolution_effective_date_is_approximate": false
  },
  "liquidator": {
    "kind": "org",
    "org_kbo": "0432.711.951",
    "org_name": "Janson",
    "person_dob": null,
    "person_rrn": null,
    "is_judicial": false,
    "person_name": null,
    "is_remunerated": true,
    "person_address": null,
    "person_birth_place": null
  },
  "silent_merger": null,
  "court_division": {
    "name": "TRIBUNAL BE L\u0027ENTREPRISE DU BRABANT WALLON",
    "language": "fr",
    "tribunal_type": "entreprise"
  },
  "books_custodian": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "SA"
  },
  "closure_mandatary": null,
  "prior_opening_ref": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Kim Lagae",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition conforme de l\u0027acte",
    "des procurations",
    "le rapport sp\u00E9cial \u00E9tabli par le conseil d\u0027administration conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport sp\u00E9cial \u00E9tabli par le commissaire conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "real_estate_transferred": [],
  "shareholder_loan_settled": null,
  "financials_at_dissolution": null,
  "distribution_to_shareholders": null
}

2023

23-06-2023 Capital increase of €5,533,714 to €21,620,314.02 Capital & shares·Kim Lagae

€16.086.600,02 → €21.620.314,02
Inbreng in geld · Apport en numéraire

Notary: Kim Lagae · Bruxelles

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 21620314.02,
      "delta_eur": 5533714.0,
      "before_eur": 16086600.02,
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": "B",
        "n_new_shares": 55336,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 5533714.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-23",
    "filing_date": "2023-06-21",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-06-13",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "rapport sp\u00E9cial du conseil d\u0027administration",
    "rapport du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 256309,
      "class_name": "B",
      "capital_share_eur": 21620314.02,
      "voting_rights_per_share": null
    }
  ]
}

02-02-2023 Capital increase of €8,000,100 to €16,086,600.01 Capital & shares·Kim LAGAE

€8.086.500,01 → €16.086.600,01

Notary: Kim LAGAE · Bruxelles

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 16086600.01,
      "delta_eur": 8000100.0,
      "before_eur": 8086500.01,
      "share_emission": {
        "agio_eur": 800010.01,
        "share_form": "nominal",
        "share_class": "B",
        "n_new_shares": 80001,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.01
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 8000100.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 80001,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": "reserves_incorporation",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim LAGAE",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-02-02",
    "filing_date": "2023-01-31",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-12-29",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "Rapport sp\u00E9cial du conseil d\u0027administration",
    "Rapports du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": null,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": null,
      "class_name": "Ordinaires sans droit de vote",
      "capital_share_eur": null,
      "voting_rights_per_share": 0.0
    },
    {
      "n_shares": null,
      "class_name": "Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": 2.0
    }
  ]
}

2022

09-02-2022 Transaction in capital or shares Capital & shares·Kim Lagae

Notary: Kim Lagae · Bruxelles

Original publication ↗

Technical details

{
  "events": [],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2022-01-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "notarieel_alleen",
    "act_date": "2022-01-17",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "PROMETHERA BIOSCIENCES Thuofeutico",
    "legal_form": "soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Kim Lagae",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire instrumentant"
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

26-01-2022 Capital increase Capital & shares·Kim Lagae

2 kapitaalbewegingen in deze akte

Notary: Kim Lagae · Bruxelles

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 5371749.98,
      "delta_eur": 5210249.98,
      "before_eur": 61500.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 52102,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 5210249.98,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "_arith_inconsistent": true,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 8086500.0,
      "delta_eur": 2814750.02,
      "before_eur": 5371749.98,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 28648,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 2814750.02,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "_arith_inconsistent": true,
      "merger_new_shares_n": 28648,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "actions_ordinaires_sans_droit_de_vote",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": 1.0,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Abda Lilly SRL",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "A Q Invest SRL",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "actions_ordinaires_sans_droit_de_vote",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": 1.0,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-01-26",
    "filing_date": "2022-01-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-01-17",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-01-17"
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Promethera Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal avec annexes",
    "procurations",
    "rapport sp\u00E9cial du conseil d\u0027administration",
    "rapports du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "Abda Lilly SRL",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "A Q Invest SRL",
      "role": null,
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 107534,
      "class_name": "actions_ordinaires",
      "capital_share_eur": 8086500.01,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 26669,
      "class_name": "actions_ordinaires_sans_droit_de_vote",
      "capital_share_eur": 0.01,
      "voting_rights_per_share": 0.0
    }
  ]
}

Credit advice verdict per customer and amount

Company registry (CBE) Crossroads Bank

Activities

Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995Speur- en ontwikkelingswerk op biotechnologisch gebied72101

Primary activity highlighted.

Names & trade names

Legal nameFR

Cellaïon

Registered office

Rue Granbonpré 11

1435 Mont-Saint-Guibert, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Comparable size · 248 of 10,551 companies in this sector with filed accounts

Intake BE 0767.722.633 · Antwerpen

Vivre à Domicile - Province de Liège BE 0811.872.677 · Liège

MEDIPLAST BE 0476.281.678 · Oud-Heverlee

Experconsult BE 0454.735.010 · Brussel

DEWEERDT - MAERTENS BE 0479.867.116 · Diksmuide